Scientific journal
Научное обозрение. Медицинские науки
ISSN 2500-0780
ПИ №ФС77-57452

Personal portfolio

DRUG PREVENTION OF FETAL GROWTH RETARDATION

Denisova T.G. 1 Vasilyeva E.N. 2 Portnova E.V. 3
1 AI of Chuvashia “Postgraduate Doctors’ Training Institute” HealthCare and Social Development Ministry of Chuvashia
2 BI “Municipal Clinical Hospital №. 1” HealthCare and Social Development Ministry of Chuvashia
3 FSEI HPE “The Chuvash State University named after I.N. Ulyanov”
Fetal growth retardation is a risk factor of central nervous system diseases, cardiovascular diseases and metabolic diseases. The following has been studied: pregnancy, labors and perinatal outcomes in 200 women with full-term pregnancy. 100 patients with early detected risk of fetal growth retardation were treated according to the developed method. Complex of medical and prevention measures have been practiced at early stage upto 18 weeks of pregnancy, at 20–24 and 30–34 weeks, that reduced the number of babies with fetal growth retardation for 3,9 times, caesarian operations for 7 times. Сomparative analysis of the newborns’ health showed that the newborns of the main group have not suffered from fetal distress though in comparative group this indicator was 13 % and the period of adaptation was less troublesome.